Diageo Settles Australian Thalidomide Suit, Law Firm Says

Diageo Plc agreed to pay A$89 million ($81 million) to settle claims from more than 100 victims of a drug that can cause birth defects, a law firm said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.